Inhibiting CML formation reduced gene and protein expression of HMG-CoAR, LDLr, SREBP-2 and SCAP in the kidney of type 2 diabetic rats. This evidence concerns the gene LDLR and chronic myelogenous leukemia, BCR-ABL1 positive.